课题基金 / 基金详情

MOLECULAR BASIS OF INHERITED DEAFNESS

MOLECULAR BASIS OF INHERITED DEAFNESS
遗传性耳聋的分子基础
批准号:
2733677
负责人:
DAVID P COREY
金额:
$19.39万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-07-01 至 2002-06-30

项目摘要

项目成果

DAVID P COREY的其他基金

相关文献

中文摘要
翻译
在这项建议中,我们概述了三个遗传基因的研究。 耳聋:编码Norrie(Norrie病)、Myosin-VIIa的基因 (引座者1B和Shaker-1鼠标)和myosin-VIIB(候选者 对于Twirler和Shaker-2小鼠突变体)。诺里研究 继续在他的赠款的头两年完成的工作,而 肌球蛋白研究启动了两个新项目。 诺里病是一种罕见的X连锁综合征耳聋, 先天性失明和进行性听力损失。我们有 克隆了这种疾病中有缺陷的基因;它编码了一种小的, 分泌蛋白(Norrin),可能是一种生长因子。这个 一些流浪者的疾病病理表明,一名有缺陷的人 Norrin允许血管过度生长--这是正常的 一种血管生成抑制剂。我们提出了几种方法来测试这一点 假设,并建议启动或继续测听和 这一缺陷的人和小鼠的组织学研究 吉恩。 引座员1B表现为契合性耳聋和缺乏 前庭功能和进行性视力丧失。它是最多的 人类常见的遗传性耳聋。基因缺陷编码 肌球蛋白VIIa,一种连接和移动其他蛋白质的蛋白质 行动。我们已经关闭了人类肌球蛋白VIIa,并使用了 用电子在听觉感受器细胞中定位它的抗体 显微镜。我们将测试一个特定的假说,肌球蛋白-VIIA 参与维持机械敏感纤毛的凝聚力, 通过使用肌球蛋白VIIa缺陷的突变小鼠Shaker-1 并通过基因转移破坏正常的肌球蛋白-VIIa 老鼠。 有证据表明,肌球蛋白-VII的其他亚型存在于 它们也可能在有缺陷时导致耳聋。 我们已经关闭了基因片段,并比较了它们的 遗传性耳聋小鼠的染色体定位。我们建议 克隆这些其他异构体,并测试它们是否为候选耳聋 基因。
英文摘要
In this proposal we outline studies on three genes for inherited deafness: those encoding Norrie (Norrie disease), myosin-VIIa (Usher 1B and the shaker-1 mouse), and myosin-VIIb (a candidate for the twirler and shaker-2 mouse mutants). The Norrie studies continue work done in the first two years of t his grant, while the myosin studies initiate two new programs. Norrie disease is a rare X-linked syndromic deafness, with congenital blindness and progressive hearing loss. We have cloned the gene defective in this disease; it encodes a small, secreted protein (norrin) that my be a growth factor. The pathology in some vagrants of the disease suggest that a defective norrin allows excessive growth of blood vessels - that it isnorally an angiogenesis inhibitor. We propose several methods to test this hypothesis, and propose to initiate or continue audiometric and histological studies of both humans and mice with this defective gene. Usher 1B presents with congenial deafness and absence of vestibular function, and progressive loss of vision. It is the most common genetic deafness in humans. The gene defective encodes myosinVIIa, a protein that connects and moves other proteins on action. We have closed human myosin-VIIa, and have used antibodies to locate it in auditory receptor cells with electron microscopy. We will test a specific hypotheses that myosin-VIIA is involved in maintaining cohesion of the mechanosensitive cilia, by using a mutant mouse, shaker-1, that has defective myosin-VIIa and by using gene transfers to disrupt myosin-VIIa in normal mice. There is evidence that other myosin-VII isoforms exist in the cochlea, and that they may also cause deafness when defective. We have closed fragments of the genes and have compared their chromosomal location to genetic deafness in mice. We propose to clone these other isoforms, and to test them as candidate deafness genes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Gene Therapy for Hereditary Deafness using Rational Protein Engineering
Gene Therapy for Hearing and Balance Disorders
  • 批准号:
    10460137
  • 项目类别:
  • 资助金额:
    $42.3万
  • 财政年份:
    2018
  • 负责人:
    DAVID P COREY
  • 依托单位:
Gene Therapy for Hearing and Balance Disorders
  • 批准号:
    10222650
  • 项目类别:
  • 资助金额:
    $42.3万
  • 财政年份:
    2018
  • 负责人:
    DAVID P COREY
  • 依托单位:
Gene Therapy for Hearing and Balance Disorders
  • 批准号:
    9978805
  • 项目类别:
  • 资助金额:
    $42.3万
  • 财政年份:
    2018
  • 负责人:
    DAVID P COREY
  • 依托单位: